Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
Saved in:
| Title: | Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer. |
|---|---|
| Authors: | McLaughlin S; Massachusetts General Hospital, Boston, MA, USA., Nakajima E; Massachusetts General Hospital, Boston, MA, USA., Bar Y; Massachusetts General Hospital, Boston, MA, USA., Hutchinson JA; Massachusetts General Hospital, Boston, MA, USA., Shin J; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kuter I; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spring LM; Attending Physician, Massachusetts General Hospital Cancer Center, Harvard Medical School, Bartlett Hall, 40R Blossom St., Boston, MA 02114, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Jan 10; Vol. 15, pp. 17588359221146133. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36643653 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McLaughlin+S%22">McLaughlin S</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nakajima+E%22">Nakajima E</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bar+Y%22">Bar Y</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hutchinson+JA%22">Hutchinson JA</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moy+B%22">Moy B</searchLink>; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kuter+I%22">Kuter I</searchLink>; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Attending Physician, Massachusetts General Hospital Cancer Center, Harvard Medical School, Bartlett Hall, 40R Blossom St., Boston, MA 02114, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2023 Jan 10; Vol. 15, pp. 17588359221146133. <i>Date of Electronic Publication: </i>2023 Jan 10 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36643653 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/17588359221146133 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17588359221146133 Titles: – TitleFull: Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McLaughlin S – PersonEntity: Name: NameFull: Nakajima E – PersonEntity: Name: NameFull: Bar Y – PersonEntity: Name: NameFull: Hutchinson JA – PersonEntity: Name: NameFull: Shin J – PersonEntity: Name: NameFull: Moy B – PersonEntity: Name: NameFull: Isakoff SJ – PersonEntity: Name: NameFull: Bardia A – PersonEntity: Name: NameFull: Kuter I – PersonEntity: Name: NameFull: Spring LM IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 01 Text: 2023 Jan 10 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1758-8340 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Therapeutic advances in medical oncology Type: main |
| ResultId | 1 |